v3.25.4
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit (Unaudited) - USD ($)
$ in Thousands
Preferred Stock
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Series C/C-1 Convertible
Common Stock
Additional paid in capital
Accumulated deficit
Total
Balance at Dec. 31, 2022 $ 5,231 $ 13,701 $ 46,217 $ 5,676 $ (105,447) $ (99,771)
Balance (in Shares) at Dec. 31, 2022 4,350,314 5,293,175 8,220,445 25,689      
Issuance of common stock upon exercise of stock options 23 23
Issuance of common stock upon exercise of stock options (in Shares) 155      
Stock-based compensation expense 33 33
Net loss (10,281) (10,281)
Balance at Dec. 31, 2023 $ 5,231 $ 13,701 $ 46,217 5,732 (115,728) (109,996)
Balance (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 25,844 [1]      
Stock-based compensation expense 5 5
Net loss (2,071) (2,071)
Balance at Mar. 31, 2024 $ 5,231 $ 13,701 $ 46,217 5,737 (117,799) (112,062)
Balance (in Shares) at Mar. 31, 2024 4,350,314 5,293,175 8,220,445 25,844 [1]      
Balance at Dec. 31, 2023 $ 5,231 $ 13,701 $ 46,217 5,732 (115,728) $ (109,996)
Balance (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 25,844 [1]      
Issuance of common stock upon exercise of stock options (in Shares)            
Net loss             $ (6,978)
Balance at Sep. 30, 2024 $ 5,231 $ 13,701 $ 46,217 5,748 (122,706) (116,958)
Balance (in Shares) at Sep. 30, 2024 4,350,314 5,293,175 8,220,445 25,844 [1]      
Balance at Dec. 31, 2023 $ 5,231 $ 13,701 $ 46,217 5,732 (115,728) (109,996)
Balance (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 25,844 [1]      
Issuance of common stock upon exercise of stock options
Stock-based compensation expense 21 21
Net loss (9,230) (9,230)
Balance at Dec. 31, 2024 $ 5,231 [1] $ 13,701 [1] $ 46,217 [1] 5,753 [1] (124,958) [1] (119,205) [1]
Balance (in Shares) at Dec. 31, 2024 [1] 4,350,314 5,293,175 8,220,445 25,844      
Balance at Mar. 31, 2024 $ 5,231 $ 13,701 $ 46,217 5,737 (117,799) (112,062)
Balance (in Shares) at Mar. 31, 2024 4,350,314 5,293,175 8,220,445 25,844 [1]      
Stock-based compensation expense 6 6
Net loss (2,410) (2,410)
Balance at Jun. 30, 2024 $ 5,231 $ 13,701 $ 46,217 5,743 (120,209) (114,466)
Balance (in Shares) at Jun. 30, 2024 4,350,314 5,293,175 8,220,445 25,844 [1]      
Stock-based compensation expense 5 5
Net loss (2,497) (2,497)
Balance at Sep. 30, 2024 $ 5,231 $ 13,701 $ 46,217 5,748 (122,706) (116,958)
Balance (in Shares) at Sep. 30, 2024 4,350,314 5,293,175 8,220,445 25,844 [1]      
Balance at Dec. 31, 2024 $ 5,231 [1] $ 13,701 [1] $ 46,217 [1] 5,753 [1] (124,958) [1] (119,205) [1]
Balance (in Shares) at Dec. 31, 2024 [1] 4,350,314 5,293,175 8,220,445 25,844      
Stock-based compensation expense 5 5
Net loss (2,716) (2,716)
Balance at Mar. 31, 2025 $ 5,231 $ 13,701 $ 46,217 5,758 (127,674) (121,916)
Balance (in Shares) at Mar. 31, 2025 4,350,314 5,293,175 8,220,445 25,844 [1]      
Balance at Dec. 31, 2024 $ 5,231 [1] $ 13,701 [1] $ 46,217 [1] 5,753 [1] (124,958) [1] $ (119,205) [1]
Balance (in Shares) at Dec. 31, 2024 [1] 4,350,314 5,293,175 8,220,445 25,844      
Issuance of common stock upon exercise of stock options (in Shares)            
Net loss             $ (27,256)
Balance at Sep. 30, 2025   118,254 (152,214) (33,960)
Balance (in Shares) at Sep. 30, 2025 [1]       556,416      
Balance at Mar. 31, 2025 $ 5,231 $ 13,701 $ 46,217 5,758 (127,674) (121,916)
Balance (in Shares) at Mar. 31, 2025 4,350,314 5,293,175 8,220,445 25,844 [1]      
Stock-based compensation expense 82 82
Net loss (2,348) (2,348)
Balance at Jun. 30, 2025 $ 5,231 $ 13,701 $ 46,217 5,840 (130,022) (124,182)
Balance (in Shares) at Jun. 30, 2025 4,350,314 5,293,175 8,220,445 25,844 [1]      
Stock-based compensation expense 189 189
Conversion of preferred stock into common stock $ (5,231) $ (13,701) $ (46,217)   65,149 65,149
Conversion of preferred stock into common stock (in Shares) (4,350,314) (5,293,175) (8,220,445) 82,377 [1]      
Common stock issued to employees 428 428
Common stock issued to employees (in Shares) [1]       6,363      
Conversion of debt to common shares in connection with the merger   46,891 46,891
Conversion of debt to common shares in connection with the merger (in Shares) [1]       197,099      
Issuance of common stock to Northview stockholders as a result of the merger   (12,346) (12,346)
Issuance of common stock to Northview stockholders as a result of the merger (in Shares) [1]       86,431      
Issuance of inducement shares to related party in connection with the merger 7,254 7,255
Issuance of inducement shares to related party in connection with the merger (in Shares) [1]       38,691      
Issuance in shares in connection with exercise of ELOC   3,537 3,537
Issuance in shares in connection with exercise of ELOC (in Shares) [1]       107,611      
Issuance of warrants in connection with exercise of ELOC Warrants 982 982
Issuance in shares in connection with exercise of ELOC Warrants
Issuance in shares in connection with exercise of ELOC Warrants (in Shares) [1]       12,000      
Issuance of warrants to financial advisor in connection with the merger 330 330
Net loss (22,192) (22,192)
Balance at Sep. 30, 2025   $ 118,254 $ (152,214) $ (33,960)
Balance (in Shares) at Sep. 30, 2025 [1]       556,416      
[1] Retroactively restated for the Reverse Stock Split as described in Note 2 and the reverse recapitalization as described in Note 3.